JPHC CE: Pediatric Psoriasis Comorbidities: Screening Recommendations for the Primary Care Provider

1.0 NAPNAP Contact Hour of which 0.25 contain Pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Psoriasis, which affects up to 2% of children may be associated with significant comorbidity, including obesity, diabetes, cardiovascular disease, depression, and reduced quality of life. Screening and decision-making require a multidisciplinary approach with the management of potential comorbidities championed by primary care providers and supported by respective specialists and subspecialists. Research into the comorbidities and systemic manifestations has generated significant data culminating in several proposals for a consensus guideline for both pediatric and nonpediatric populations. Our aim is to provide a summary targeted to the pediatric primary care provider from the best available evidence when caring for children with psoriasis. J Pediatr Health Care. (2021) 35, 337−350

Important: You must be logged in to use your NAPNAP Member ID# and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any information.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

Copyright © 2021 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved. 

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours of which 0.25 contain pharmacology content.

Keywords: Psoriasis, pediatrics, primary care, comorbidities, screening
 

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

  • Discuss the epidemiology of pediatric psoriasis.
  • Describe the clinical presentation of pediatric psorisis and commonly encountered subtypes
  • Describe the common comorbidities in children with psoriasis.
  • Summarize current screening recommendations for pediatric psoriasis patients, with a focus on the pri-mary care setting.
     
Course summary
Available credit: 
  • 1.00 Contact hours
Course opens: 
05/14/2021
Course expires: 
06/30/2022
Cost:
$10.00
Rating: 
5

Bianca Y. Kang, Student, Creighton University School of Medicine, Creighton University, Phoenix Regional Campus, Phoenix, AZ.
Judith O’Haver, Pediatric Nurse Practitioner and Nursing Scientist, Department of Pediatric Dermatology, Phoenix Children’s Hospital, Phoenix, AZ.
Israel D. Andrews, Associate Program Director, Department of Pediatric Dermatology, Phoenix Children’s Hospital, Phoenix, AZ.


Conflicts of interest: None to report.


Correspondence: Bianca Y. Kang, BS, Creighton University School of Medicine, Creighton University, Phoenix Regional Campus, 350 W. Thomas Rd., Phoenix, AZ 85013;; e-mail: BiancaKang@creighton.edu.
 

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours of which 0.25 contain pharmacology content.

Available Credit

  • 1.00 Contact hours

Price

Cost:
$10.00
Please login or register to take this course.